U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Lixisenatide (ADLYXIN) Injection
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Sanofi (New 02/03/2023)

Company Contact Information:
800-633-1610

Presentation Posting Date Related Information
Adlyxin™ (lixisenatide) injection 10mcg (NDC 00024-5745-02) 3mL single patient use pen Starter Pack: Contains 1 single-patient-use prefilled green pen of ADLYXIN 10 mcg (50 mcg/mL and delivers 14 doses of 10 mcg) (NDC 0024-5741-01) and 1 single-patient-use prefilled burgundy pen of ADLYXIN 20 mcg (100 mcg/mL and delivers 14 doses of 20 mcg) (NDC 0024-5740-00) 02/03/2023 Product expiry date is 9/30/2023 (Marketing End Date)
Adlyxin™ (lixisenatide) injection 20mcg (NDC 00024-5747-02) 3mL single patient use pen Maintenance Pack NDC: Contains 2 single-patient-use prefilled burgundy pens for ADLYXIN 20 mcg (100 mcg/mL and delivers 14 doses of 20 mcg) (NDC 0024-5740-00) 02/03/2023 Product expiry date is 9/30/2023 (Marketing End Date)
Back to Top